Literature DB >> 8996602

Mechanisms of topoisomerase I inhibition by anticancer drugs.

Y Pommier1, A Tanizawa, K W Kohn.   

Abstract

Mesh：

Substances：

Year:  1994        PMID： 8996602     DOI： 10.1016/s1054-3589(08)61132-1

Source DB:  PubMed          Journal:  Adv Pharmacol        ISSN： 1054-3589


× No keyword cloud information.
  17 in total

Review 1.  Review of systemic therapies for locally advanced and metastatic rectal cancer.

Authors:  Patrick Yaffee; Arsen Osipov; Carlyn Tan; Richard Tuli; Andrew Hendifar
Journal:  J Gastrointest Oncol       Date:  2015-04

2.  A eukaryotic enzyme that can disjoin dead-end covalent complexes between DNA and type I topoisomerases.

Authors:  S W Yang; A B Burgin; B N Huizenga; C A Robertson; K C Yao; H A Nash
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-15       Impact factor: 11.205

3.  In the presence of subunit A inhibitors DNA gyrase cleaves DNA fragments as short as 20 bp at specific sites.

Authors:  H Gmünder; K Kuratli; W Keck
Journal:  Nucleic Acids Res       Date:  1997-02-01       Impact factor: 16.971

4.  Induction of topoisomerase I cleavage complexes by 1-beta -D-arabinofuranosylcytosine (ara-C) in vitro and in ara-C-treated cells.

Authors:  P Pourquier; Y Takebayashi; Y Urasaki; C Gioffre; G Kohlhagen; Y Pommier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

Review 5.  Iron chelators with topoisomerase-inhibitory activity and their anticancer applications.

Authors:  V Ashutosh Rao
Journal:  Antioxid Redox Signal       Date:  2012-10-26       Impact factor: 8.401

6.  Schedule-dependent cytotoxicity of 5-fluorouracil and irinotecan in a colon cancer cell line.

Authors:  Yasuhiro Inoue; Chikao Miki; Hideki Watanabe; Junichiro Hiro; Yuji Toiyama; Eiki Ojima; Hidenori Yanagi; Masato Kusunoki
Journal:  J Gastroenterol       Date:  2007-02-06       Impact factor: 7.527

7.  Synergistic enhancement of topotecan-induced cell death by ascorbic acid in human breast MCF-7 tumor cells.

Authors:  Birandra K Sinha; Thomas J van 't Erve; Ashutosh Kumar; Carl D Bortner; Ann G Motten; Ronald P Mason
Journal:  Free Radic Biol Med       Date:  2017-10-24       Impact factor: 7.376

8.  Identification of the aminocatechol A-3253 as an in vitro poison of DNA topoisomerase I from Candida albicans.

Authors:  J Fostel; D Montgomery
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

9.  Therapeutic activity of CPT-11, a DNA-topoisomerase I inhibitor, against peripheral primitive neuroectodermal tumour and neuroblastoma xenografts.

Authors:  G Vassal; M J Terrier-Lacombe; M C Bissery; A M Vénuat; F Gyergyay; J Bénard; J Morizet; I Boland; P Ardouin; B Bressac-de-Paillerets; A Gouyette
Journal:  Br J Cancer       Date:  1996-08       Impact factor: 7.640

10.  Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells.

Authors:  Ashutosh Kumar; Marilyn Ehrenshaft; Erik J Tokar; Ronald P Mason; Birandra K Sinha
Journal:  Biochim Biophys Acta       Date:  2016-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.